Gerson SL - Search Results

1

Wadhwa PD, Zielske SP, Roth JC, Ballas CB, Bowman JE, Gerson SL. Wadhwa PD, et al. Among authors: gerson sl. Annu Rev Med. 2002;53:437-52. doi: 10.1146/annurev.med.53.082901.104039. Annu Rev Med. 2002. PMID: 11818484 Review.

2

Adult bone marrow stem cells for cell and gene therapies: implications for greater use.

Ballas CB, Zielske SP, Gerson SL. Ballas CB, et al. Among authors: gerson sl. J Cell Biochem Suppl. 2002;38:20-8. doi: 10.1002/jcb.10127. J Cell Biochem Suppl. 2002. PMID: 12046846 Review.

3

Hematopoietic stem cell gene therapy: progress toward therapeutic targets.

Vollweiler JL, Zielske SP, Reese JS, Gerson SL. Vollweiler JL, et al. Among authors: gerson sl. Bone Marrow Transplant. 2003 Jul;32(1):1-7. doi: 10.1038/sj.bmt.1704081. Bone Marrow Transplant. 2003. PMID: 12815471 Review.

4

Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro.

Zielske SP, Gerson SL. Zielske SP, et al. Among authors: gerson sl. Mol Ther. 2002 Apr;5(4):381-7. doi: 10.1006/mthe.2002.0571. Mol Ther. 2002. PMID: 11945064 Free article.

5

Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells.

Zielske SP, Gerson SL. Zielske SP, et al. Among authors: gerson sl. Mol Ther. 2003 Mar;7(3):325-33. doi: 10.1016/s1525-0016(03)00005-4. Mol Ther. 2003. PMID: 12668128 Free article.

6

Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients.

Bowman JE, Reese JS, Lingas KT, Gerson SL. Bowman JE, et al. Among authors: gerson sl. Mol Ther. 2003 Jul;8(1):42-50. doi: 10.1016/s1525-0016(03)00141-2. Mol Ther. 2003. PMID: 12842427 Free article.

7

SarCNU mediates selection of P140K methylguanine-DNA-methyltransferase transduced human CD34(+) cells in vitro.

Zielske SP, Gerson SL. Zielske SP, et al. Among authors: gerson sl. Blood Cells Mol Dis. 2003 Jul-Aug;31(1):48-50. doi: 10.1016/s1079-9796(03)00060-3. Blood Cells Mol Dis. 2003. PMID: 12850483

8

Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatment.

Zielske SP, Lingas KT, Li Y, Gerson SL. Zielske SP, et al. Among authors: gerson sl. Mol Ther. 2004 Jun;9(6):923-31. doi: 10.1016/j.ymthe.2004.02.017. Mol Ther. 2004. PMID: 15194059 Free article.

9

Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cells.

Lin Y, Cheung P, Roth JC, Wilson DL, Gerson SL. Lin Y, et al. Among authors: gerson sl. Mol Ther. 2011 Jul;19(7):1342-52. doi: 10.1038/mt.2010.315. Epub 2011 Feb 8. Mol Ther. 2011. PMID: 21304493 Free PMC article.

10

In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning.

Zielske SP, Reese JS, Lingas KT, Donze JR, Gerson SL. Zielske SP, et al. Among authors: gerson sl. J Clin Invest. 2003 Nov;112(10):1561-70. doi: 10.1172/JCI17922. J Clin Invest. 2003. PMID: 14617757 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters